Palliat Med. 2010 Oct;24(7):696-706. Epub 2010 Jul 29.

A formal feasibility study of sublingual methadone for breakthrough cancer pain.

Hagen NA, Moulin DE, Brasher PM, Biondo PD, Eliasziw M, Watanabe SM, Stiles CR.

Source

Alberta Health Services Cancer Care, Tom Baker Cancer Centre, Calgary, Alberta, Canada. neil.hagen@albertahealthservices.ca

Abstract

We conducted a feasibility study of sublingual methadone for breakthrough cancer pain, to determine whether a larger, randomized trial was warranted, and to identify a study design that would be likely to succeed. From approximately 1930 patients in the initial pool, nine patients were enrolled. Five patients completed the study, generating data on 83 discrete episodes of breakthrough cancer pain at optimal dose. Mean pain intensity dropped by 1.7 points (on a 10 point numerical scale) within 10 min of sublingual methadone administration, and by 3.2 points after 15 min. No serious or severe toxicity was encountered. Based on the results of this feasibility study, a larger randomized clinical trial of sublingual methadone for breakthrough cancer pain using this trial model would not be successful. Extensive information obtained from small numbers of carefully studied patients provides proof of concept that sublingual methadone is effective, safe, and well tolerated.

PMID:: 20671005; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Education

New England Research Institutes Inc.

Medical

Molecular Biology Databases

METHADONE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Sublingual methadone for the management of cancer-related breakthrough pain: a pilot study. [J Palliat Med. 2007]
Sublingual methadone for the management of cancer-related breakthrough pain: a pilot study.
Hagen NA, Fisher K, Stiles C. J Palliat Med. 2007 Apr; 10(2):331-7.
Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain. [Curr Med Res Opin. 2009]
Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain.
Rauck RL, Tark M, Reyes E, Hayes TG, Bartkowiak AJ, Hassman D, Nalamachu S, Derrick R, Howell J. Curr Med Res Opin. 2009 Dec; 25(12):2877-85.
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). [Pain Pract. 2008]
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, et al. Pain Pract. 2008 Jul-Aug; 8(4):287-313. Epub 2008 May 23.
Sublingual fentanyl orally disintegrating tablet in daily practice: efficacy, safety and tolerability in patients with breakthrough cancer pain. [Curr Med Res Opin. 2011]
Sublingual fentanyl orally disintegrating tablet in daily practice: efficacy, safety and tolerability in patients with breakthrough cancer pain.
Überall MA, Müller-Schwefe GH. Curr Med Res Opin. 2011 Jul; 27(7):1385-94. Epub 2011 May 11.
Review Methadone for cancer pain. [Cochrane Database Syst Rev. 2004]
Review Methadone for cancer pain.
Nicholson AB. Cochrane Database Syst Rev. 2004; (2):CD003971.

See reviews... See all...

Cited by 1 PubMed Central article

Reporting characteristics of cancer pain: a systematic review and quantitative analysis of research publications in palliative care journals. [Indian J Palliat Care. 2011]
Reporting characteristics of cancer pain: a systematic review and quantitative analysis of research publications in palliative care journals.
Kumar SP. Indian J Palliat Care. 2011 Jan; 17(1):57-66.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

A formal feasibility study of sublingual methadone for breakthrough cancer pain.
A formal feasibility study of sublingual methadone for breakthrough cancer pain.
Palliat Med. 2010 Oct ;24(7):696-706. Epub 2010 Jul 29 .

PubMed
Scaling up a school-based sexual and reproductive health intervention in rural T...
Scaling up a school-based sexual and reproductive health intervention in rural Tanzania: a process evaluation describing the implementation realities for the teachers.
Health Educ Res. 2010 Dec ;25(6):903-16. Epub 2010 Jul 29 .

PubMed
Adenovirus targeting to prostate-specific membrane antigen through virus-display...
Adenovirus targeting to prostate-specific membrane antigen through virus-displayed, semirandom peptide library screening.
Cancer Res. 2010 Dec 1 ;70(23):9549-53. Epub 2010 Jul 29 .

PubMed
Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and ci...
Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck.
Clin Cancer Res. 2010 Aug 1 ;16(15):4005-15.

PubMed
DNA damage signaling recruits the Rtt107-Slx4 scaffolds via Dpb11 to mediate rep...
DNA damage signaling recruits the Rtt107-Slx4 scaffolds via Dpb11 to mediate replication stress response.
Mol Cell. 2010 Jul 30 ;39(2):300-6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

A formal feasibility study of sublingual methadone for breakthrough cancer pain.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Education

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information